Breaking News Instant updates and real-time market news.

BPMC

Blueprint Medicines

$106.16 /

-1.92 (-1.78%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

15:17
12/01/20
12/01
15:17
12/01/20
15:17

Blueprint Medicines announces FDA approval of Gavreto

Blueprint Medicines Corporation (BPMC) announced that the U.S. Food and Drug Administration has approved GAVRETO for the treatment of patients with RET-altered thyroid cancers. The accelerated approval expands the labeled indications for GAVRETO to include adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer who require systemic therapy, or with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory. Developed by Blueprint Medicines, GAVRETO is a once-daily oral precision therapy designed to potently and selectively target RET alterations that drive multiple tumor types. GAVRETO is jointly commercialized in the U.S. by Blueprint Medicines and Genentech, a wholly owned member of the Roche Group, under Blueprint Medicines' collaboration with Roche (RHHBY). In the Phase 1/2 ARROW trial, GAVRETO showed durable efficacy and was generally well-tolerated in patients with RET-altered thyroid cancers with or without prior systemic therapy. Earlier this year, the FDA granted accelerated approval to GAVRETO for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancer as detected by an FDA approved test.

BPMC

Blueprint Medicines

$106.16 /

-1.92 (-1.78%)

RHHBY

Roche

$0.00 /

+ (+0.00%)

  • 08

    Dec

  • 23

    Jan

BPMC Blueprint Medicines
$106.16 /

-1.92 (-1.78%)

11/02/20 Jefferies
Jefferies cuts Blueprint to Hold with current products' potential priced in
11/02/20 H.C. Wainwright
Blueprint Medicines price target raised to $135 from $110 at H.C. Wainwright
11/02/20 Jefferies
Blueprint Medicines downgraded to Hold from Buy at Jefferies
10/30/20
Fly Intel: Top five analyst downgrades
RHHBY Roche
$0.00 /

+ (+0.00%)

11/27/20 UBS
Roche price target lowered to CHF 365 from CHF 370 at UBS
11/11/20 Truist
Opthea initiated with a Buy at Truist
10/16/20 UBS
Roche price target lowered to CHF 370 from CHF 390 at UBS
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data

TODAY'S FREE FLY STORIES

Recommendations
Telos price target raised to $45 from $31 at Needham » 09:03
01/19/21
01/19
09:03
01/19/21
09:03
TLS

Telos

$37.75 /

+3.26 (+9.45%)

Needham analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TLS Telos
$37.75 /

+3.26 (+9.45%)

TLS Telos
$37.75 /

+3.26 (+9.45%)

01/12/21 B. Riley Securities
Telos price target raised to $40 from $34.50 at B. Riley Securities
12/23/20 Northland
Telos price target raised to $33 from $26 at Northland
12/14/20 Needham
Telos initiated with a Buy at Needham
12/14/20 Colliers
Telos initiated with a Buy at Colliers
  • 19
    Nov
TLS Telos
$37.75 /

+3.26 (+9.45%)

Hot Stocks
Green Plains announces Clean Sugar Project at Nebraska innovation center » 09:03
01/19/21
01/19
09:03
01/19/21
09:03
GPRE

Green Plains

$17.54 /

-0.87 (-4.73%)

Green Plains and Ospraie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPRE Green Plains
$17.54 /

-0.87 (-4.73%)

GPRE Green Plains
$17.54 /

-0.87 (-4.73%)

01/06/21 Roth Capital
Green Plains price target raised to $20 from $11 at Roth Capital
10/19/20
Fly Intel: Top five analyst initiations
10/19/20 Truist
Green Plains initiated with a Buy at Truist
08/05/20 Craig-Hallum
Green Plains price target raised to $18 from $11 at Craig-Hallum
GPRE Green Plains
$17.54 /

-0.87 (-4.73%)

Hot Stocks
Royal Caribbean agrees to sell Azamara brand to Sycamore in $201M transaction » 09:03
01/19/21
01/19
09:03
01/19/21
09:03
RCL

Royal Caribbean

$72.94 /

-2.87 (-3.79%)

Royal Caribbean announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCL Royal Caribbean
$72.94 /

-2.87 (-3.79%)

RCL Royal Caribbean
$72.94 /

-2.87 (-3.79%)

01/15/21 Deutsche Bank
Royal Caribbean price target raised to $62 from $46 at Deutsche Bank
10/30/20 Stifel
CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel
10/30/20 Deutsche Bank
Royal Caribbean price target raised to $46 from $43 at Deutsche Bank
10/16/20 Deutsche Bank
Deutsche sees Covid newsflow remaining drag on cruise stocks
RCL Royal Caribbean
$72.94 /

-2.87 (-3.79%)

  • 14
    Oct
RCL Royal Caribbean
$72.94 /

-2.87 (-3.79%)

RCL Royal Caribbean
$72.94 /

-2.87 (-3.79%)

RCL Royal Caribbean
$72.94 /

-2.87 (-3.79%)

Upgrade
QTS Realty Trust upgraded to Strong Buy from Outperform at Raymond James » 09:03
01/19/21
01/19
09:03
01/19/21
09:03
QTS

QTS Realty Trust

$61.59 /

+1.535 (+2.56%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QTS QTS Realty Trust
$61.59 /

+1.535 (+2.56%)

QTS QTS Realty Trust
$61.59 /

+1.535 (+2.56%)

04:49 Today Raymond James
QTS Realty Trust upgraded to Strong Buy from Outperform at Raymond James
12/08/20 Capital One
QTS Realty Trust initiated with an Overweight at Capital One
12/03/20 Mizuho
Mizuho initiates data center REIT sector with positive outlook
12/02/20 Mizuho
QTS Realty Trust initiated with a Buy at Mizuho
QTS QTS Realty Trust
$61.59 /

+1.535 (+2.56%)

  • 02
    Jun
Hot Stocks
Well + Good launches content-driven e-commerce marketplace » 09:02
01/19/21
01/19
09:02
01/19/21
09:02
LEAF

Leaf Group

$4.91 /

-0.13 (-2.58%)

Well+Good announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LEAF Leaf Group
$4.91 /

-0.13 (-2.58%)

LEAF Leaf Group
$4.91 /

-0.13 (-2.58%)

01/07/21 Canaccord
Leaf Group estimates raised following strong preliminary results at Canaccord
10/16/20 Canaccord
Leaf Group price target raised to $9 from $7 at Canaccord
LEAF Leaf Group
$4.91 /

-0.13 (-2.58%)

  • 10
    Dec
LEAF Leaf Group
$4.91 /

-0.13 (-2.58%)

Upgrade
Equinix upgraded to Strong Buy from Outperform at Raymond James » 09:01
01/19/21
01/19
09:01
01/19/21
09:01
EQIX

Equinix

$707.60 /

+17.63 (+2.56%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EQIX Equinix
$707.60 /

+17.63 (+2.56%)

EQIX Equinix
$707.60 /

+17.63 (+2.56%)

04:47 Today Raymond James
Equinix upgraded to Strong Buy from Outperform at Raymond James
12/03/20 Mizuho
Mizuho initiates data center REIT sector with positive outlook
12/02/20 Mizuho
Equinix initiated with a Buy at Mizuho
11/03/20 RBC Capital
Equinix price target lowered to $825 from $845 at RBC Capital
EQIX Equinix
$707.60 /

+17.63 (+2.56%)

  • 12
    May
Hot Stocks
Milestone Scientific signs distribution agreements for Wand anesthesia system » 09:01
01/19/21
01/19
09:01
01/19/21
09:01
MLSS

Milestone Scientific

$2.75 /

+0.12 (+4.56%)

Milestone Scientific has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MLSS Milestone Scientific
$2.75 /

+0.12 (+4.56%)

MLSS Milestone Scientific
$2.75 /

+0.12 (+4.56%)

09/16/20 Northland
Milestone Scientific initiated with a Market Perform at Northland
MLSS Milestone Scientific
$2.75 /

+0.12 (+4.56%)

  • 26
    Jun
Hot Stocks
Cognizant to acquire Magenic Technologies, terms not disclosed » 09:01
01/19/21
01/19
09:01
01/19/21
09:01
CTSH

Cognizant

$80.25 /

+0.15 (+0.19%)

Cognizant has entered…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTSH Cognizant
$80.25 /

+0.15 (+0.19%)

CTSH Cognizant
$80.25 /

+0.15 (+0.19%)

01/06/21 Wolfe Research
Cognizant upgraded to Peer Perform from Underperform at Wolfe Research
12/29/20 Credit Suisse
Cognizant price target raised to $91 from $79 at Credit Suisse
12/18/20 Wells Fargo
Cognizant resumed with an Overweight at Wells Fargo
12/11/20 JPMorgan
Cognizant upgraded to Overweight with $93 target at JPMorgan
CTSH Cognizant
$80.25 /

+0.15 (+0.19%)

CTSH Cognizant
$80.25 /

+0.15 (+0.19%)

CTSH Cognizant
$80.25 /

+0.15 (+0.19%)

CTSH Cognizant
$80.25 /

+0.15 (+0.19%)

Hot Stocks
Capital Southwest supports O2's investment in Flip Electronics » 09:01
01/19/21
01/19
09:01
01/19/21
09:01
CSWC

Capital Southwest

$18.22 /

-0.27 (-1.46%)

, MAIN

Main Street

$32.32 /

+0.11 (+0.34%)

Capital Southwest…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSWC Capital Southwest
$18.22 /

-0.27 (-1.46%)

MAIN Main Street
$32.32 /

+0.11 (+0.34%)

CSWC Capital Southwest
$18.22 /

-0.27 (-1.46%)

11/24/20 B. Riley Securities
Capital Southwest price target raised to $16 from $14 at B. Riley Securities
11/05/20
Fly Intel: Top five analyst initiations
11/05/20 JMP Securities
Capital Southwest resumed with an Outperform at JMP Securities
06/04/20 JMP Securities
Capital Southwest price target lowered to $17 from $22.50 at JMP Securities
MAIN Main Street
$32.32 /

+0.11 (+0.34%)

08/12/20 Truist
Main Street price target raised to $33 from $28 at Truist
04/15/20 National Securities
Main Street downgraded to Neutral from Buy at National Securities
03/17/20 National Securities
Main Street upgraded to Buy from Neutral at National Securities
CSWC Capital Southwest
$18.22 /

-0.27 (-1.46%)

MAIN Main Street
$32.32 /

+0.11 (+0.34%)

CSWC Capital Southwest
$18.22 /

-0.27 (-1.46%)

Hot Stocks
Neovasc Reducer featured in three peer-reviewed publications » 09:00
01/19/21
01/19
09:00
01/19/21
09:00
NVCN

Neovasc

$1.19 /

+0.005 (+0.42%)

Neovasc announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVCN Neovasc
$1.19 /

+0.005 (+0.42%)

NVCN Neovasc
$1.19 /

+0.005 (+0.42%)

07/09/20 SVB Leerink
Reducer could be meaningful revenue contributor for Neovasc, says SVB Leerink
05/08/20 H.C. Wainwright
Neovasc price target lowered to $5 from $9 at H.C. Wainwright
04/13/20
Fly Intel: Top five analyst initiations
04/13/20 Noble Capital
Neovasc initiated with an Outperform at Noble Capital
NVCN Neovasc
$1.19 /

+0.005 (+0.42%)

Hot Stocks
Veru's enobosarm androgen receptor shows tumor suppresion in published study » 08:59
01/19/21
01/19
08:59
01/19/21
08:59
VERU

Veru

$8.89 /

-0.76 (-7.88%)

Veru announced the online…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VERU Veru
$8.89 /

-0.76 (-7.88%)

VERU Veru
$8.89 /

-0.76 (-7.88%)

12/16/20 Oppenheimer
Veru price target raised to $19 from $9 at Oppenheimer
12/15/20 H.C. Wainwright
Veru price target raised to $12 from $8 at H.C. Wainwright
12/14/20 Cantor Fitzgerald
Veru price target raised to $15 from $6 at Cantor Fitzgerald
12/11/20 Brookline
Veru price target raised to $17 from $13 at Brookline
VERU Veru
$8.89 /

-0.76 (-7.88%)

VERU Veru
$8.89 /

-0.76 (-7.88%)

Downgrade
Staar Surgical downgraded to Hold on valuation at Benchmark » 08:59
01/19/21
01/19
08:59
01/19/21
08:59
STAA

Staar Surgical

$88.12 /

-2.92 (-3.21%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STAA Staar Surgical
$88.12 /

-2.92 (-3.21%)

STAA Staar Surgical
$88.12 /

-2.92 (-3.21%)

06:02 Today Benchmark
Staar Surgical downgraded to Hold from Buy at Benchmark
11/09/20 Canaccord
Staar Surgical price target raised to $84 from $70 at Canaccord
10/26/20 Sidoti
Staar Surgical downgraded to Neutral from Buy at Sidoti
08/31/20
Fly Intel: Top five analyst upgrades
STAA Staar Surgical
$88.12 /

-2.92 (-3.21%)

Hot Stocks
Avinger provides update on intellectual property portfolio » 08:58
01/19/21
01/19
08:58
01/19/21
08:58
AVGR

Avinger

$1.47 /

+0.37 (+33.64%)

Avinger provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVGR Avinger
$1.47 /

+0.37 (+33.64%)

AVGR Avinger
$1.47 /

+0.37 (+33.64%)

04/13/20 Ladenburg
Ladenburg cuts Avinger to Neutral on impact of COVID-19 on elective procedures
04/13/20 Ladenburg
Avinger downgraded to Neutral from Buy at Ladenburg
  • 21
    Aug
  • 04
    Aug
  • 24
    Jun
  • 28
    Apr
  • 29
    Jan
Hot Stocks
Tarsus Pharmaceuticals appoints Bryan Wahl as general counsel » 08:58
01/19/21
01/19
08:58
01/19/21
08:58
TARS

Tarsus Pharmaceuticals

$43.49 /

-0.93 (-2.09%)

Tarsus Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TARS Tarsus Pharmaceuticals
$43.49 /

-0.93 (-2.09%)

TARS Tarsus Pharmaceuticals
$43.49 /

-0.93 (-2.09%)

11/10/20 Raymond James
Tarsus Pharmaceuticals initiated with a Strong Buy at Raymond James
11/10/20 Jefferies
Tarsus Pharmaceuticals initiated with a Buy at Jefferies
11/10/20 Ladenburg
Tarsus Pharmaceuticals initiated with a Buy at Ladenburg
11/10/20 BofA
Tarsus Pharmaceuticals initiated with a Buy at BofA
  • 16
    Oct
TARS Tarsus Pharmaceuticals
$43.49 /

-0.93 (-2.09%)

Upgrade
Digital Realty upgraded to Strong Buy from Outperform at Raymond James » 08:57
01/19/21
01/19
08:57
01/19/21
08:57
DLR

Digital Realty

$136.49 /

+3.08 (+2.31%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DLR Digital Realty
$136.49 /

+3.08 (+2.31%)

DLR Digital Realty
$136.49 /

+3.08 (+2.31%)

04:48 Today Raymond James
Digital Realty upgraded to Strong Buy from Outperform at Raymond James
12/18/20 TD Securities
Digital Realty upgraded to Buy from Hold at TD Securities
12/14/20 KeyBanc
Digital Realty downgraded to Sector Weight from Overweight at KeyBanc
12/03/20 Deutsche Bank
Digital Realty named 'Catalyst Call: Buy Idea' at Deutsche Bank
DLR Digital Realty
$136.49 /

+3.08 (+2.31%)

DLR Digital Realty
$136.49 /

+3.08 (+2.31%)

Recommendations
MongoDB price target raised to $394 from $341 at Needham » 08:57
01/19/21
01/19
08:57
01/19/21
08:57
MDB

MongoDB

$360.78 /

-3.3 (-0.91%)

Needham analyst Jack…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDB MongoDB
$360.78 /

-3.3 (-0.91%)

MDB MongoDB
$360.78 /

-3.3 (-0.91%)

01/15/21 Stifel
Elastic upgraded to Buy after licensing changes at Stifel
01/13/21 Citi
MongoDB price target raised to $465 from $354 at Citi
01/13/21 Citi
Elastic price target raised to $190 from $160 at Citi
01/11/21 Barclays
MongoDB price target raised to $435 from $331 at Barclays
MDB MongoDB
$360.78 /

-3.3 (-0.91%)

MDB MongoDB
$360.78 /

-3.3 (-0.91%)

MDB MongoDB
$360.78 /

-3.3 (-0.91%)

Hot Stocks
Aptinyx announces NYX-2925 data published » 08:57
01/19/21
01/19
08:57
01/19/21
08:57
APTX

Aptinyx

$4.12 /

+0.32 (+8.42%)

Aptinyx announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APTX Aptinyx
$4.12 /

+0.32 (+8.42%)

APTX Aptinyx
$4.12 /

+0.32 (+8.42%)

12/21/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Aptinyx after competitor fails in PTSD
11/19/20 H.C. Wainwright
Aptinyx price target raised to $8 from $7 at H.C. Wainwright
11/12/20 Piper Sandler
Aptinyx pipeline catalysts on track, says Piper Sandler
10/28/20 Cantor Fitzgerald
Aptinyx price target raised to $12 from $9 at Cantor Fitzgerald
APTX Aptinyx
$4.12 /

+0.32 (+8.42%)

  • 22
    Oct
APTX Aptinyx
$4.12 /

+0.32 (+8.42%)

APTX Aptinyx
$4.12 /

+0.32 (+8.42%)

Earnings
BioElectronics reports Q4 revenue over $519,000 » 08:56
01/19/21
01/19
08:56
01/19/21
08:56
BIEL

BioElectronics

$0.00 /

+ (+0.00%)

BioElectronics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIEL BioElectronics
$0.00 /

+ (+0.00%)

Hot Stocks
BofA: Consumer spending has continued to increase in January vs. last year  08:55
01/19/21
01/19
08:55
01/19/21
08:55
BAC

Bank of America

$33.02 /

-0.97 (-2.85%)

 
ShowHide Related Items >><<
BAC Bank of America
$33.02 /

-0.97 (-2.85%)

BAC Bank of America
$33.02 /

-0.97 (-2.85%)

01/11/21 Citi
Bank of America upgraded to Buy from Neutral at Citi
01/11/21 Citi
Bank of America upgraded to Buy from Neutral at Citi
01/11/21 Piper Sandler
Bank of America price target raised to $36 from $28 at Piper Sandler
01/06/21 Deutsche Bank
Bank of America price target raised to $35 from $30 at Deutsche Bank
BAC Bank of America
$33.02 /

-0.97 (-2.85%)

BAC Bank of America
$33.02 /

-0.97 (-2.85%)

BAC Bank of America
$33.02 /

-0.97 (-2.85%)

BAC Bank of America
$33.02 /

-0.97 (-2.85%)

Options
Notable open interest changes for January 19th » 08:55
01/19/21
01/19
08:55
01/19/21
08:55
AAPL

Apple

$127.07 /

-1.92 (-1.49%)

, AMD

AMD

$88.16 /

-2.62 (-2.89%)

, NIO

NIO Inc.

$56.27 /

-4.62 (-7.59%)

, WFC

Wells Fargo

$32.04 /

-2.72 (-7.83%)

Friday's total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$127.07 /

-1.92 (-1.49%)

AMD AMD
$88.16 /

-2.62 (-2.89%)

NIO NIO Inc.
$56.27 /

-4.62 (-7.59%)

WFC Wells Fargo
$32.04 /

-2.72 (-7.83%)

AAPL Apple
$127.07 /

-1.92 (-1.49%)

05:02 Today BMO Capital
Facebook upgraded to Outperform from Market Perform at BMO Capital
01/15/21 Goldman Sachs
Goldman Sachs raises short-term forecasts for Apple, maintains Sell rating
01/15/21 Loop Capital
Apple price target raised to $155 from $131 at Loop Capital
01/14/21 Barclays
Apple price target raised to $116 from $100 at Barclays
AMD AMD
$88.16 /

-2.62 (-2.89%)

01/14/21 Cowen
AMD price target raised to $110 from $100 at Cowen
01/14/21 BMO Capital
Intel upgraded to Outperform from Market Perform at BMO Capital
01/14/21 BMO Capital
AMD downgraded to Underperform from Market Perform at BMO Capital
01/13/21 Citi
Citi opens positive catalyst watch on Intel, boosts target to $55 after CEO news
NIO NIO Inc.
$56.27 /

-4.62 (-7.59%)

07:02 Today Jefferies
NIO Inc. initiated with a Hold at Jefferies
01/11/21 Citi
Citi downgrades NIO Inc. to Neutral after unveiling of 'good but not enough' ET7
01/11/21 Deutsche Bank
NIO Inc. price target raised to $70 from $50 at Deutsche Bank
01/11/21 Citi
NIO Inc. downgraded to Neutral from Buy at Citi
WFC Wells Fargo
$32.04 /

-2.72 (-7.83%)

08:43 Today Seaport Global
Wells Fargo upgraded to Buy from Neutral at Seaport Global
08:13 Today Baird
Wells Fargo risk/reward remains attractive, says Baird
01/18/21 Keefe Bruyette
Wells Fargo price target raised to $38 from $36 at Keefe Bruyette
01/12/21 UBS
UBS downgrades Citizens on revenue headwinds, Wells new top pick
AAPL Apple
$127.07 /

-1.92 (-1.49%)

AMD AMD
$88.16 /

-2.62 (-2.89%)

NIO NIO Inc.
$56.27 /

-4.62 (-7.59%)

WFC Wells Fargo
$32.04 /

-2.72 (-7.83%)

  • 14
    Dec
  • 31
    Aug
  • 11
    Jun
AAPL Apple
$127.07 /

-1.92 (-1.49%)

AMD AMD
$88.16 /

-2.62 (-2.89%)

NIO NIO Inc.
$56.27 /

-4.62 (-7.59%)

WFC Wells Fargo
$32.04 /

-2.72 (-7.83%)

AAPL Apple
$127.07 /

-1.92 (-1.49%)

AMD AMD
$88.16 /

-2.62 (-2.89%)

NIO NIO Inc.
$56.27 /

-4.62 (-7.59%)

WFC Wells Fargo
$32.04 /

-2.72 (-7.83%)

AAPL Apple
$127.07 /

-1.92 (-1.49%)

AMD AMD
$88.16 /

-2.62 (-2.89%)

NIO NIO Inc.
$56.27 /

-4.62 (-7.59%)

WFC Wells Fargo
$32.04 /

-2.72 (-7.83%)

General news
Oil Action: WTI crude » 08:55
01/19/21
01/19
08:55
01/19/21
08:55

Oil Action: WTI crude…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Nevro price target raised to $210 from $190 at SVB Leerink » 08:55
01/19/21
01/19
08:55
01/19/21
08:55
NVRO

Nevro

$175.11 /

-0.555 (-0.32%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$175.11 /

-0.555 (-0.32%)

NVRO Nevro
$175.11 /

-0.555 (-0.32%)

07:28 Today Canaccord
Nevro price target raised to $203 from $167 at Canaccord
01/06/21 Truist
Nevro price target raised to $205 from $175 at Truist
01/05/21 Baird
Nevro price target raised to $200 from $180 at Baird
01/04/21 Wells Fargo
Nevro price target raised to $215 from $177 at Wells Fargo
NVRO Nevro
$175.11 /

-0.555 (-0.32%)

  • 02
    Apr
NVRO Nevro
$175.11 /

-0.555 (-0.32%)

Conference/Events
Williams to host Virtual ESG Event » 08:55
01/19/21
01/19
08:55
01/19/21
08:55
WMB

Williams

$22.50 /

-0.19 (-0.84%)

Virtual ESG Event to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMB Williams
$22.50 /

-0.19 (-0.84%)

WMB Williams
$22.50 /

-0.19 (-0.84%)

12/17/20 Credit Suisse
Williams upgraded to Outperform from Neutral at Credit Suisse
12/11/20 Morgan Stanley
Morgan Stanley upgrades midstream industry view to Attractive, shakes up ratings
12/11/20 Morgan Stanley
Williams downgraded to Equal Weight from Overweight at Morgan Stanley
12/03/20 SMBC Nikko
Williams initiated with an Outperform at SMBC Nikko
WMB Williams
$22.50 /

-0.19 (-0.84%)

WMB Williams
$22.50 /

-0.19 (-0.84%)

WMB Williams
$22.50 /

-0.19 (-0.84%)

Hot Stocks
Royalty Pharma acquires royalty interest in Seltorexant from Minerva » 08:54
01/19/21
01/19
08:54
01/19/21
08:54
RPRX

Royalty Pharma

$51.83 /

+0.57 (+1.11%)

, NERV

Minerva

$2.71 /

+0.03 (+1.12%)

, JNJ

Johnson & Johnson

$160.28 /

-0.37 (-0.23%)

Royalty Pharma (RPRX) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RPRX Royalty Pharma
$51.83 /

+0.57 (+1.11%)

NERV Minerva
$2.71 /

+0.03 (+1.12%)

JNJ Johnson & Johnson
$160.28 /

-0.37 (-0.23%)

RPRX Royalty Pharma
$51.83 /

+0.57 (+1.11%)

11/09/20
Fly Intel: Top five analyst upgrades
11/09/20 UBS
Royalty Pharma upgraded to Buy from Neutral at UBS
07/20/20 SunTrust
PTC Therapeutics price target raised to $86 from $75 at SunTrust
07/13/20 Cowen
Cowen starts Royalty Pharma with Outperform, $55 price target
NERV Minerva
$2.71 /

+0.03 (+1.12%)

12/01/20 JMP Securities
Minerva laid out path to roluperidone submission, says JMP Securities
07/01/20 JMP Securities
Minerva's seltorexant still 'underappreciated' upside driver, says JMP
06/08/20 H.C. Wainwright
Minerva price target lowered to $10 from $20 at H.C. Wainwright
06/05/20 JMP Securities
Minerva reinstated with an Outperform at JMP Securities
JNJ Johnson & Johnson
$160.28 /

-0.37 (-0.23%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
RPRX Royalty Pharma
$51.83 /

+0.57 (+1.11%)

NERV Minerva
$2.71 /

+0.03 (+1.12%)

JNJ Johnson & Johnson
$160.28 /

-0.37 (-0.23%)

  • 16
    Oct
  • 16
    Jun
JNJ Johnson & Johnson
$160.28 /

-0.37 (-0.23%)

JNJ Johnson & Johnson
$160.28 /

-0.37 (-0.23%)

JNJ Johnson & Johnson
$160.28 /

-0.37 (-0.23%)

Recommendations
II-VI price target raised to $98 from $71 at Needham » 08:54
01/19/21
01/19
08:54
01/19/21
08:54
IIVI

II-VI

$88.33 /

-0.35 (-0.39%)

Needham analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IIVI II-VI
$88.33 /

-0.35 (-0.39%)

IIVI II-VI
$88.33 /

-0.35 (-0.39%)

01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
12/18/20 Benchmark
II-VI price target raised to $85 from $65 at Benchmark
12/15/20 Morgan Stanley
II-VI downgraded to Equal Weight following outperformance at Morgan Stanley
12/15/20 Morgan Stanley
II-VI downgraded to Equal Weight from Overweight at Morgan Stanley
IIVI II-VI
$88.33 /

-0.35 (-0.39%)

  • 02
    Jul
IIVI II-VI
$88.33 /

-0.35 (-0.39%)

IIVI II-VI
$88.33 /

-0.35 (-0.39%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.